NanoString Technologies
#10438
Rank
$5.07M
Marketcap
United States
Country
Mr. R. Bradley Gray (CEO, Pres & Director)
Mr. K. Thomas Bailey M.B.A. (Chief Financial Officer)
Dr. Joseph M. Beechem (Chief Scientific Officer and Sr. VP of R&D)
Summary
History
NanoString was founded in 2003 to pursue the commercialization of a patented technology invented by Dr. Mark Niedergang, a research scientist at the Fred Hutchinson Cancer Research Center in Seattle, Washington. NanoString’s commercialization efforts were largely successful and its trademarked “nCounter Analysis System” rapidly gained acceptance in both clinical and research laboratories around the world.
Mission
Vision
Key Team
Mr. J. Chad Brown (Sr. Advisor)
Mr. Mark A. Winham (Sr. VP of Operations)
Mr. Douglas S. Farrell (VP of Investor Relations & Corp. Communications)
Ms. Kathryn Surace-Smith (Sr. VP of HR & Legal Affairs and Corp. Sec.)
Mr. David W. Ghesquiere (Sr. VP of Corp. & Bus. Devel.)
Elizabeth Schneider Ph.D. (Sr. Global Marketing Mang.)
Dr. Mary Tedd Allen (Sr. VP of Strategic Initiatives)
Recognition and Awards
References
https://en.wikipedia.org/wiki/NanoString_Technologies
https://in.investing.com/equities/nanostrg-te
https://finance.yahoo.com/quote/NSTG/profile?p=NSTG
https://www.comparably.com/companies/nanostring-technologies/mission
https://www.crunchbase.com/organization/nanostring-technologies
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Mr. R. Bradley Gray (CEO, Pres & Director)
Mr. K. Thomas Bailey M.B.A. (Chief Financial Officer)
Dr. Joseph M. Beechem (Chief Scientific Officer and Sr. VP of R&D)
